Zim ready for long term injectable PrEP-MoHCC

IN a bid to increase adherence to Antiretroviral Therapy (ART) in Zimbabwe, the Ministry of Health and Child Care (MoHCC) said it welcomes obtaining studies to advance prevention therapy through long term injectable Pre-Exposure prophylaxes medications. By Staff Reporter This follows the approval of Apretude (cabotegravir extended-release injectable suspension) in 2021 by the U.S. Food and Drug Administration. This will be taken in at-risk adults and adolescents weighing at least 35 kilograms (77 pounds) for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV. However, in Zimbabwe, current…

Read More

#BREAKING: Dapivirine, Vaginal Ring Approved For Use In Zimbabwe

IN what is likely to be a major breakthrough for Zimbabwe’s HIV response, the Dapivirine or Vaginal Ring, a tool meant to expand HIV prevention options for women has been approved for use in Zimbabwe, HealthTimes has learnt. By Michael Gwarisa The Vaginal ring was submitted to the Medicines Control Authority of Zimbabwe (MCAZ) for review on March, 5 2021 and according to MCAZ procedures, approval for a medical drug or innovation usually takes between three months or a few years, depending on the completeness of the technical information that…

Read More